The medtech company Peptonic has determined the subscription price for warrants of series TO6 at SEK 0.0011 per share. The exercise period begins on June 1 and runs until June 12.If fully exercised, the company can raise approximately SEK 12.5 million before issue costs. This corresponds to dilution of approximately 35.46 percent. The outcome is expected to be announced around June 15.